Medical University of Gdansk
gumed.edu.plTotal trials
123
Active
40
Phase 3
4
Total enrollment
125,884
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 15 of 15 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| remimazolam sedation reversal with flumazenil | — | — | — | — | — | 1 | |
| Metoprolol Succinate | — | — | — | — | — | 1 | |
| Nivolumab 10 MG/ML | — | — | — | — | — | 1 | |
| Palbociclib | — | — | — | — | — | 1 | |
| Paclitaxel | — | — | — | — | — | 1 | |
| Carboplatin | — | — | — | — | — | 1 | |
| Clozapine | — | — | — | — | — | 1 | |
| Cholecalciferol | — | — | — | — | — | 1 | |
| Ketamine Hydrochloride | — | — | — | — | — | 1 | |
| Intensified intravenous omeprazole therapy | — | — | — | — | — | 1 | |
| Standard intravenous omeprazole therapy (40 mg IV once daily at 6:00 AM). | — | — | — | — | — | 1 | |
| Different drug type for conduction of general anesthesia | — | — | — | — | — | 1 | |
| Apixaban | — | — | — | — | — | 1 | |
| Rivaroxaban | — | — | — | — | — | 1 | |
| low molecular weight heparin | — | — | — | — | — | 1 |
Next readouts
- 2022-09-30
- 2023-06-30
- 2024-12-31
- 2025-01-01
- 2026-04-01
- 2026-04-30
- 2026-12-31
- 2027-06
- 2027-10
- 2029-12-31
Top conditions
- Chronic Kidney Disease5
- Proteinuria5
- Healthy4
- Acute Kidney Injury4
- Major Depressive Disorder3
- Manual Therapy3
- Manipulation3
- Muscles3
Frequently asked questions about Medical University of Gdansk
- How many clinical trials does Medical University of Gdansk have on ClinicalTrials.gov?
- Medical University of Gdansk is listed as the lead sponsor on 123 clinical trials in ClinicalTrials.gov, 40 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Medical University of Gdansk's trials are in Phase 3?
- 4 of Medical University of Gdansk's trials are in Phase 3, spread across 15 active drug programs.
- What therapeutic areas does Medical University of Gdansk focus on?
- Medical University of Gdansk's most-studied conditions on ClinicalTrials.gov are Chronic Kidney Disease, Proteinuria, Healthy, Acute Kidney Injury, Major Depressive Disorder.
- When are Medical University of Gdansk's next clinical trial readouts?
- Medical University of Gdansk has 10 upcoming primary-completion readouts tracked here; the soonest is “Radiation Free Chemotherapy for Early Hodgkin Lymphoma”, expected around 2022-09-30.